Tibulizumab

Drug identity checked against registry records

Also recorded as ZB-106

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)NCT06843239Zura Bio IncPhase 2Active not recruiting2027-05Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.